Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

UNBELIEVABLE: 9 - The Untold Story

1 Stock That Could Easily Beat the Market Over the Next 5 Years

Pfizer (PFE) benefited substantially from the COVID-19 pandemic. It pays a more than 3% dividend, making it attractive for investors looking for stable income. The stock has picked up steady momentum, and its robust fundamentals should help the company easily outpace the market in the coming years. Let’s discuss this…

StockNews.com

3 High-Yield Dividend Stocks With Upside Potential Right Now

Amid the stock market chaos due to the Fed’s fight against inflation and recessionary concerns, dividend stocks are gaining traction. Fundamentally strong dividend stocks can provide protection and ensure stable income. So, high-yield dividend stocks Pfizer (PFE), BHP Group (BHP), and Caledonia Mining (CMCL), with significant upside potential, might be…

StockNews.com

This 1 Stock Can Weather Any Recession

Pfizer (PFE) has been a COVID beneficiary and is expected to continue to gain from its vaccines as the pandemic war is yet to be over. Moreover, PFE offers a more than 3% dividend. Thus, investors might consider buying this quality stock which seems well-positioned to weather any recession. Keep…

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

1 COVID-19 Stock That's Still a Buy and 1 That's Not

Covid cases continue to get registered to date, and the Biden administration is attempting to allocate more funding to address the pandemic. While investors should consider buying quality COVID-19 stock Pfizer (PFE), we think Teladoc Health (TDOC) might be best avoided now, considering its weak fundamentals. Keep reading….

StockNews.com

3 Intriguing Stocks to Buy for the Santa Claus Rally

With festive spending keeping the economy resilient despite the threat of interest rate hikes, it could be wise to invest in Pfizer (PFE), Broadcom (AVGO), and Restaurants Brands International (QSR) to give your portfolios a touch of holiday spirit. Continue reading….

StockNews.com

2 Stocks to Help You Build a Healthy Portfolio for the Long Term

Despite rampant economic headwinds, the U.S. job market remains tight and resilient. Although the uncertainties remain, investors should stay invested and focus on their long-term strategies. Therefore, quality stocks Pfizer (PFE) and Agilent Technologies (A) could be ideal picks to build a healthy portfolio for the long term. Keep reading….

StockNews.com

5 Amazing Stocks You Won’t Ever Regret Buying

Easing inflation and the Fed’s indication of slowing the pace of interest rate hikes are raising investors’ sentiments. Moreover, the November job report came in better than expected. While uncertainties remain, we think quality stocks Pfizer (PFE), AstraZeneca PLC (AZN), Carrier Global (CARR), J. Jill (JILL), and Lifeway Foods (LWAY)…

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

2 Stocks That Have Wall Street's Stamp of Approval

Despite rampant market volatility ahead of the November jobs data, and possible recession fears, experts believe the U.S. economy is resilient enough to handle a potential growth slowdown. Given the possibility of a year-end rally, quality stocks Pfizer (PFE) and AT&T (T) could now be ideal additions to your portfolio.…

StockNews.com

3 Stocks That Still Have Room to Run

With the October inflation report showing signs of cooling and anticipations of a slowdown in interest rate hikes, the stock market looks poised to extend its recent rally. Hence, it could be wise to invest in fundamentally sound stocks Pfizer (PFE), Cisco Systems (CSCO), and Raytheon Technologies (RTX) that still…

StockNews.com

1 High-Dividend Stock to Add to Your Portfolio if You Haven’t Already

Amid prevalent COVID-19 cases, vaccine pioneer Pfizer (PFE) is significantly benefiting. Moreover, the company beat wall street expectations in the third quarter with a robust financial result and raised its revenue and EPS guidance for the year. Given its strong fundamentals, the stock could be a wise addition to your…

StockNews.com

3 Pharmaceutical Stocks to Invest in This Month

The pharmaceutical industry is rapidly evolving to meet today’s health challenges. The pharmaceutical industry's long-term prospects look bright with a globally aging population set to increase healthcare expenditure. Moreover, given the industry’s ability to stay resilient amid economic headwinds, it could be wise to invest in fundamentally strong pharmaceutical stocks…

StockNews.com

3 Strong Buy Stocks to Continue to Hold Onto in 2023

As the Fed’s aggressive monetary policy resulted in slightly cooled inflation last month, investors are hopeful of smaller rate hikes ahead. However, since a recession is expected to hit the economy next year, we think fundamentally sound stocks Pfizer (PFE), Flowers Foods (FLO), and Xperi (XPER), which are rated Strong…

StockNews.com

2 Strong Stocks to Consider Buying This November

While market volatility is still prevalent, experts believe the U.S. economy might succeed in achieving a 'soft landing.' Moreover, most S&P 500 companies surpassed revenue and EPS estimates in the third quarter. Therefore, fundamentally sound stocks Pfizer (PFE) and Flowers Foods (FLO) could be ideal additions to your portfolio now.…

StockNews.com

3 Dividend Stocks to Buy to Help Soothe Some of Your Pain

Although inflation eased slightly last month, the Fed has indicated that the final level of interest rates could be higher than expected. With further interest rate hikes and the possibility of a recession expected to keep the market under pressure, it could be wise to buy dividend-paying stocks Pfizer (PFE),…

StockNews.com

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

Could Pfizer Stock Help You Retire a Millionaire?

Leading biopharmaceutical company Pfizer’s (PFE) third-quarter results demonstrated strength across most areas of its business. Moreover, the company raised its 2022 financial guidance for revenues and adjusted EPS. Also, the company has increased its dividend for 12 consecutive years, and its annual dividend yields more than 3%. Given its solid…

StockNews.com

3 Stocks Wall Street Loves

Amid the ongoing macroeconomic and geopolitical issues, the stock market has faced wild swings this year. As the sky-high inflation and the Fed’s aggressive rate hikes continue to heighten recessionary fears, Wall Street darlings Microsoft (MSFT), Pfizer (PFE), and Coca-Cola (KO), which have a solid dividend-paying record, might be ideal…

StockNews.com

2 Stocks to Help You Beat the Bear Market Blues

The Fed’s aggressive rate hikes to tame the stubborn inflation have led to widespread recession fears. The stock market has witnessed a significant selloff. Moreover, as the bear market seems not over yet, we think fundamentally strong dividend-paying stocks, Pfizer (PFE) and Kroger (KR), might help you beat the bear…

StockNews.com

3 Strong Stocks to Buy Before the Next Bull Market

The economy is showing resilience despite the Fed’s aggressive rate hikes. Moreover, Goldman Sachs’ top economist believes the economy might succeed in avoiding a recession. We think investors could buy fundamentally sound stocks Pfizer (PFE), Cisco Systems (CSCO), and United Parcel (UPS) before the next bull market. Read on….

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

2 Stocks to Buy if You're Looking to Make Passive Income

Despite rampant macro headwinds, job growth in October surpassed estimates. Moreover, President Joe Biden remains confident that the country's economy will rebound shortly. Investors looking to make passive income could now add quality dividend stocks Pfizer (PFE) and PepsiCo (PEP) to their portfolios. Keep reading….

StockNews.com

2 Stocks You Can Count on for Reliable Dividends

The Fed announced its fourth consecutive 75-bps rate hike this week. However, the Fed's aggression is expected to shrink eventually. Amid rampant market volatility, investor sentiment toward dividend stocks is robust. Therefore, fundamentally sound stocks Pfizer (PFE) and Caledonia Mining (CMCL) could be solid picks for a steady income stream.…

StockNews.com

These 3 Stocks Are a Must When Building Your Dividend Portfolio

Since the uncertain economic conditions are expected to keep the stock market under pressure, dividend-paying stocks Pfizer (PFE), ICL Group (ICL), and ARC Document Solutions (ARC) could be solid additions to your portfolio for generating a steady income stream. Keep reading….

StockNews.com

Here Are 3 Stocks to Buy Under $50 in Q4

Although the stock market has been under pressure this year, many believe bulls will overtake the bears in 2023. Moreover, the U.S. economy’s third-quarter GDP surpassed growth estimates, easing recession fears to some extent. Therefore, this could be the right time to scoop up quality stocks Pfizer (PFE), Ryerson Holding…

StockNews.com

3 Stocks That Are Great for Passive Income Investors

Though the U.S. economy bounced back after shrinking in the first half of the year, falling consumer spending and the rate hikes to tame high inflation might lead the economy into a recession. Hence, investors looking for passive income could invest in fundamentally sound dividend-paying stocks Pfizer (PFE), Sanofi (SNY),…

StockNews.com

2 Health Care Stocks You Can Always Count On

With inflation showing no signs of slowing down, the chances of another 75-bps rate hike are increasing. Investing in healthcare stocks tends to help investors hedge against economic downturns. And given the sound prospects of the healthcare sector, fundamentally sound healthcare stocks Pfizer (PFE) and Humana (HUM) could be good…

Benzinga

What Are Whales Doing With Pfizer

Someone with a lot of money to spend has taken a bullish stance on Pfizer (NYSE:PFE). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

1 … 8 9 10 11

People

Dipanjan BanchurSince

722 stories

Mangeet Kaur BounsMangeet

595 stories

Santanu RoyHaving

215 stories

Sristi Suman Jayaswal

90 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Microsoft Corporation

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.